Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-09-25 | 2024-06 | 0 | N/A | N/A | N/A |
2024-05-15 | 2024-03 | 0 | -0.52 | N/A | N/A |
2024-02-14 | 2023-12 | 0 | -0.04 | N/A | N/A |
2023-11-14 | 2023-09 | 0 | -1.48 | N/A | N/A |
2023-09-27 | 2023-06 | 0 | 0.16 | N/A | N/A |
2023-05-11 | 2023-03 | 0 | -1.93 | N/A | N/A |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-08 | Maxim Group | Upgrade | Buy | |
2023-05-30 | HC Wainwright & Co. | Upgrade | Buy | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2021-04-15 | CANTRELL GARY V. | Director | 204.09K | Stock Award(Grant) |
2023-06-13 | DISBROW JOSHUA R. | Chief Executive Officer | 71.59K | Purchase |
2023-08-10 | DOCKERY CARL C | Director | 8.94K | Stock Award(Grant) |
2021-04-07 | HECHT BETH P | Director | 9.05K | Stock Award(Grant) |
2023-08-15 | JAIN ABHINAV | Director | 8.00K | Stock Award(Grant) |
2023-08-10 | LIU VIVIAN H | Director | 1.84K | Stock Award(Grant) |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Nantahala Capital Management, LLC | 1.09M | 1.74M | 19.65% |
2023-06-29 | Stonepine Capital Management, LLC | 472.37K | 755.79K | 8.54% |
2023-06-29 | Renaissance Technologies, LLC | 57.32K | 91.72K | 1.04% |
2023-06-29 | Blackrock Inc. | 24.06K | 38.49K | 0.44% |
2023-06-29 | Acadian Asset Management. LLC | 22.54K | 36.06K | 0.41% |
2023-06-29 | Prudential Financial, Inc. | 19.58K | 31.32K | 0.35% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Extended Market Index Fund | 9.99K | 15.99K | 0.18% |
2023-05-30 | Fidelity Extended Market Index Fund | 8.71K | 14.55K | 0.16% |
2023-05-30 | Fidelity Series Total Market Index Fund | 1.59K | 2.66K | 0.03% |
2023-05-30 | Fidelity Total Market Index Fund | 1.59K | 2.65K | 0.03% |
2023-08-30 | iShares Core S&P Total U.S. Stock Market ETF | 1.27K | 2.15K | 0.02% |
Split | Date |
---|---|
1 : 20 | 2023-01-06 |
1 : 10 | 2020-12-09 |
1 : 20 | 2018-08-13 |
1 : 20 | 2017-08-29 |
1 : 12 | 2016-07-01 |
82 : 1000 | 2015-06-10 |
-
$AYTU you need to understand the importance of doing these test, otherwise we will never recover.
-
$AYTU NEED LITTLE BRAIN TO UNDERSTAND TO NOONE CARES ABOUT NEWS ABOUT THIS SHIT!!!!!!
-
$AYTU SO FUNNY .... people still talking about kits or news. No one cares man your kits or your news......
-
The test kits licensed by AYTU for exclusive distribution in North America from Zhejiang Orient Gene Biotech Company are featured in this Fox video from today.
https://finance.yahoo.com/quote/AYTU/community?p=AYTU
Looks like the kits may already be on the ground and are being distributed. Great to be invested in a company that can really help us through this crisis. GLTA and stay healthy!
-
-
This company is for real and there are plenty of interested parties focused on bringing these kits into the US market.
For review:
Here is the press release on AYTU licensing the Point-of-care rapid test (from L.B. resources, LTD.) as manufactured by Zhejiang Orient Gene Biotech Co., LTD.
This article may also be found on Zhejieng’s website. See below link. They are also publicly traded.
-
Pence said they added 1/2 million jobs but forgot to mention the 100 million lost jobs. Lol
-
$AYTU The orange is babbling about Tom Brady instead of test kits
-
$AYTU Do not listen to the bears trying to scare you. The article clearly says the test kits were made by a different company, not Healgen or AYTU.
-
Insiders at AYTU are likely pacing the floors with a press release drafted and ready to go - pending delivery/release of the kits. They seem to be doing everything right... expanding distribution rights, seeking and receiving regulatory approvals, and fundraising to firm up their balance sheet and provide sufficient runway to further distribution rights and capabilities. If you want to sift through all of the facts in one place, just go to SEC.gov and you will find the latest public filings. There seems to be good transparency, and there are a number of new shareholders - sophisticated investors - who are likely putting real pressure on the executive team to deliver. I expect to see things play out soon. Perhaps we will have our day much like Henry Schein (HSIC) shareholders did today.
-
-
$AYTU be patient this will go to $25 very soon, the 100 000 test kits are already sold, Polis ordered a lot so did Pitkin county, these are just e few who have already purchased the kits. They are relabeling, going through FDA and then the news will come. Just be patient!!!
-
$AYTU, Australia receives 500 000 Covid-19 rapid test. https://www.kiis1065.com.au/lifestyle/health-beauty/new-rapid-covid-19-tests-that-provide-results-in-15-minutes-are-being-rolled-out-next-week/
-
Antibody testing will allow us to identify those that are immune to COVID-19, and these individuals can go back to work in the economy.
-
If anyone this the market rebounded today think again. It’s a dead cat voice and will drop much more in days/weeks ahead. This virus is far from being contained.
-
-
Aytu BioPharma, Inc. (AYTU) Q3 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q2 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma, Inc. (AYTU) Q1 2024 Earnings Call Transcript
seekingalpha.com • -
Aytu BioPharma Reports Fiscal 2024 First Quarter Financial Results
accesswire.com • -
Best Penny Stocks? 4 Hot Stocks With News This Week
pennystocks.com • -
Aytu BioPharma, Inc. (AYTU) Q4 2023 Earnings Call Transcript
seekingalpha.com •